 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Sequenta Tests LymphoSight Assay for Monitoring Residual Disease in Two Clinical Trials
August 15, 2012
Sequenta Tests LymphoSight Assay for Monitoring Residual Disease in Two Clinical Trials
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Sequenta Readies ClonoSight for 2013 Launch with CLIA Certification and Clinical Validation Studies
October 24, 2012 / Clinical Sequencing News - Sequenta Shows its Immune Sequencing Method Can Predict Relapse in Cancer Patients
December 14, 2011 / Clinical Sequencing News - HudsonAlpha Researchers to Sequence Immune Repertoires of 10K Individuals for 100 Diseases
May 24, 2011 / Clinical Sequencing News - Startup MDx Firm Sequenta Raises $13M in Series B
December 8, 2010 / GenomeWeb Daily News - OHSU Team Uses Sequencing to ID Drug Targets, Dx Markers for Two Types of Leukemia
May 15, 2013 / Clinical Sequencing News